Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with this brand-new episode, which sees the pair return to the airwaves to share more brilliant insights from experts in the pharmaceutical industry.   In this first episode, Isabel discusses customer experience with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD. In the conversation, Philippe reveals what pharma is getting right and wrong, how to get valuable and actionable feedback from customers, how to balance customer experience and compliance and much more.   All views are Philippe's own and not those of his company. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Upgrading the personal touch in CX Crafting customer experience 5 ways pharma can ensure omnichannel success

The GOLD team are delighted to announce that Season 5 of The GOLD Podcast is just around the corner. To mark the run up to the next series, Isabel and Jade take a moment in this episode to reminisce about some of the hot topics our brilliant guests shared with us in Season 4.    Join our hosts as they journey through their ‘GOLD medal moments’ from last season, covering topics such as the rise of AI, the importance of empathy in leadership, the fight for representation in organisations and more.  If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  Behind the hype of ChatGPT: https://www.emg-gold.com/post/behind-the-hype-of-chatgpt  Taking women to the top of pharma: https://www.emg-gold.com/post/taking-women-to-the-top-of-pharma  Raising women’s health up the agenda: https://www.emg-gold.com/post/raising-women-s-health-up-the-agenda  Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation 

To mark the final episode of Season 4, Isabel and Jade reminisce about their favourite moments from the series and give an exclusive teaser for the next issue of GOLD – out on 13 April.   Expect discussion on topics such as the current state of life sciences innovation in the UK, the latest advances and potential of personalised medicine, a deep dive into our Catalyst interview with Christi Shaw, former CEO, Kite Pharma, and lots of bonus insights from the writers themselves.    Be sure to subscribe here to receive the full issue straight to your inbox on publication day.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Pharma in the UK Mapping a path to personalised medicine

In the penultimate episode of Season 4, the GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and experience within the pharmaceutical industry. Isabel and Zsuzsanna explore a wide range of topics during their conversation, including diversity and inclusion, the importance of climbing the ranks of leadership at the right pace, ensuring personalised medicines can reach patients in need and much more.  If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  Elevating pharma’s parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies  Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future  Driving access to all medicines: https://www.emg-gold.com/post/driving-access-to-all-medicines  Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action 

This week on the GOLD Podcast, Isabel and Jade present a conversation with Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, about how pharmaceutical teams can make the most of a tight budget and leverage digital transformation for the benefit of customers and patients. During their discussion, Jade and Gaurav delve into his transition from retail to pharma, explore how companies can make quick wins by leveraging modular content and omnichannel and how AI is facilitating the digital transformation of marketing strategies. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:   Upgrading the personal touch in CX https://www.emg-gold.com/post/upgrading-the-personal-touch-in-cx  AI, ChatGPT and modernising medical affairs https://www.emg-gold.com/post/ai-chatgpt-and-modernising-medical-affairs  Super reps, ChatGPT and pharma’s future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media 

This week on the GOLD podcast, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in the pharmaceutical industry and the potential uses of ChatGPT in medical affairs. In this episode, Matt explores the need to modernise medical affairs, top ways pharma teams could save time and resources with ChatGPT, the likelihood of AI one day becoming as commonplace as electricity and much more.    If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  Is medical affairs the Ferrari of the pharma industry?: https://www.emg-gold.com/post/podcast-is-medical-affairs-the-ferrari-of-the-pharma-industry  Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation  Super reps, ChatGPT and pharma’s future on social media: https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media  Revealing the true value of medical affairs: https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs 

This week on the GOLD podcast, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation, to discuss all things access within the pharmaceutical industry. In this episode, Claudia and Jade explore a range of topics, including the story behind her passion for access to medicine, the industry's progress in making medicines more widely available in low- and middle-income countries and the Foundation's latest focus on driving access to generic drugs.  If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  Claudia’s first GOLD Podcast: https://www.emg-gold.com/post/podcast-talking-to-claudia-martinez  Pharma in Kenya: https://www.emg-gold.com/post/pharma-in-kenya Pharma in India: https://www.emg-gold.com/post/pharma-in-india 

This week, the GOLD team is delighted to bring you a special International Women's Day (IWD) podcast featuring Pallavi Bansal, Associate Vice President of Oncology, Genitourinary Cancers and Haematology, Merck, and Emma Chaffin, Vice President, Country Head and Site Lead, Galapagos. The two women reflect on this year's IWD theme, #EmbracingEquity, why female representation in pharma is so important and how leaders can foster a sense of belonging within their organisations. Isabel and Jade also discuss the latest GOLD content on female representation and equality in pharma.  Additional resources:  If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  Infographic: Attracting more diverse talent into STEM https://www.emg-gold.com/_files/ugd/b8a9db_153874fc1b484455a9d2840f3118317c.pdf  Elevating pharma’s parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies  Reverse mentoring: a how-to guide: https://www.emg-gold.com/post/reverse-mentoring-a-how-to-guide  Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future  HBA Gender Parity Collaborative https://genderparity.hbanet.org/ 

This week, Isabel catches up with GOLD’s long-time friend Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS. She asks Bora to break down the value of the medical affairs function, asking whether it is being properly utilised by pharma organisations. Bora also shares his thoughts on the future of the MSL, what skills new recruits will need to succeed and his top predictions for the next five years in MA. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs Mastering medical affairs https://www.emg-gold.com/post/mastering-medical-affairs Darshan Kulkarni on Super reps, ChatGPT and pharma’s future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media

This week, GOLD talks to Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm, which focuses on regulatory and compliance for life sciences, about key trends in medical affairs and marketing today. He discusses whether MSLs will one day replace sales reps, the role of ChatGPT in healthcare, pharma’s future on social media and much more. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: The feature Darshan contributed to: Confronting health inequities for transgender patients https://www.emg-gold.com/post/confronting-health-inequities-for-transgender-patients A takeover, a tweet and trouble for pharma marketers https://www.emg-gold.com/post/a-takeover-a-tweet-trouble-for-pharma-marketers Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight Davidek Herron on 5 ways pharma can ensure omnichannel success https://www.emg-gold.com/post/5-ways-pharma-can-ensure-omnichannel-success-davidek-herron Mental health matters in pharma's approach to care https://www.emg-gold.com/post/mental-health-matters-in-pharma-s-approach-to-care